Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when OCUL files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsOcular Therapeutix Chief Strategy Officer Sanjay Nayak resigns to lead private company
Filed October 16, 2026 · Period ending October 14, 2026 · ~1 min read
Key Changes
-
medium
Chief Strategy Officer Sanjay Nayak resigned effective October 16, 2026, to become CEO of a privately-held company.
Item 5.02 verify on EDGAR →
Summary
Ocular Therapeutix disclosed that its Chief Strategy Officer, Sanjay Nayak, resigned effective October 16, 2026. He is leaving to become the Chief Executive Officer of a privately-held company. The filing does not name a successor or describe any transition arrangements.
The departure removes a senior strategy executive from the company. For retail holders, the key question is whether the company will backfill the role and how strategy execution continues in the interim. The filing itself does not indicate any disagreement or broader management disruption.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Oct 19, 2026 · How we verify